Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 18,608 shares at $55.73 ($1.0M) on 2026-05-05, disclosed to the SEC on 2026-05-07.
Scheduled sale ($1.0M) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.73 | 6,264 | $349K | 34.3% |
| 2 | $56.37 | 776 | $44K | 4.3% |
| 3 | $57.18 | 5,634 | $322K | 31.7% |
| 4 | $58.13 | 1,406 | $82K | 8.0% |
| 5 | $47.59 | 1,350 | $64K | 6.3% |
| 6 | $48.31 | 1,149 |
| $56K |
| 5.5% |
| 7 | $49.19 | 2,029 | $100K | 9.8% |
| Total | $54.61 avg | 18,608 | $1.0M | 100% |
| Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |
| PAHC | SELL | 2026-03-26 | $2.3M | — | Filing → |